tailieunhanh - báo cáo hóa học:" Confronting TB/HIV in the era of increasing anti-TB drug resistance"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : Confronting TB/HIV in the era of increasing anti-TB drug resistance | Journal of the International AIDS Society BioMed Central Open Access Review Confronting TB HIV in the era of increasing anti-TB drug resistance Jeremiah Chakaya 1 Haileyesus Getahun2 Reuben Granich3 and Diane Havlir4 Address 1Centre for Respiratory Diseases Research Kenya Medical Research Institute Africa 2Stop TB Department World Health Organization Geneva Switzerland 3HIV Department World Health Organization Geneva Switzerland and 4University of California San Francisco USA Email Jeremiah Chakaya - Haileyesus Getahun - getahunh@ Reuben Granich - granichr@ Diane Havlir - dhavlir@ Corresponding author Published 6 November 2008 Received 19 August 2008 - . J . n - r - r Accepted 6 November 2008 Journal of the International AIDS Society 2008 11 6 doi 1758-2652-11-6 This article is available from http content 11 1 6 2008 Chakaya et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract HIV associated TB is a major public health problem. In 2006 it was estimated that there were over 700 000 people who suffered from HIV associated TB of whom about 200 000 have died. The burden of HIV associated TB is greatest in Sub-Saharan Africa where the TB epidemic is primarily driven by HIV. There has been steady progress made in reducing the burden of HIV in TB patients with an increasing number of TB patients tested for HIV and provided with cotrimoxazole preventive therapy CPT and anti-retroviral treatment ART . Less progress is being made to reduce the burden of TB in people living with HIV. The number of HIV infected persons reported to have been screened for TB was less than 1 while Isoniazid preventive therapy was reported to have been provided to less than